Informa (LON:INF – Get Free Report) had its price objective upped by Citigroup from GBX 990 to GBX 1,090 in a research report issued on Wednesday,Digital Look reports. The firm currently has a “buy” rating on the stock. Citigroup’s price target would indicate a potential upside of 21.06% from the stock’s previous close.
Several other research firms also recently issued reports on INF. Berenberg Bank boosted their price objective on shares of Informa from GBX 965 to GBX 1,040 and gave the stock a “buy” rating in a report on Friday, July 31st. JPMorgan Chase & Co. reduced their target price on shares of Informa from GBX 1,300 to GBX 1,285 and set an “overweight” rating for the company in a research note on Thursday, July 2nd. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 1,140 target price on shares of Informa in a research report on Friday, July 31st. Six analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of GBX 1,135.
Informa Trading Down 0.2%
Informa (LON:INF – Get Free Report) last released its earnings results on Thursday, July 30th. The company reported GBX 26.70 EPS for the quarter. Informa had a net margin of 5.43% and a return on equity of 3.90%. As a group, sell-side analysts predict that Informa will post 59.3240265 EPS for the current year.
Insider Buying and Selling at Informa
In other news, insider Gareth Wright bought 222 shares of Informa stock in a transaction that occurred on Wednesday, May 20th. The stock was purchased at an average cost of GBX 809 per share, with a total value of £1,795.98. Also, insider Stephen A. Carter purchased 222 shares of the firm’s stock in a transaction on Wednesday, May 20th. The shares were acquired at an average price of GBX 809 per share, for a total transaction of £1,795.98. 0.24% of the stock is owned by company insiders.
About Informa
Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.
We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.
And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.
Recommended Stories
- Five stocks we like better than Informa
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Receive News & Ratings for Informa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Informa and related companies with MarketBeat.com's FREE daily email newsletter.
